The role of CD28- cells in human Chagas' disease

Information

  • Research Project
  • 7449775
  • ApplicationId
    7449775
  • Core Project Number
    R03AI066044
  • Full Project Number
    5R03AI066044-02
  • Serial Number
    66044
  • FOA Number
    PAS-04-111
  • Sub Project Id
  • Project Start Date
    7/1/2007 - 17 years ago
  • Project End Date
    6/30/2010 - 14 years ago
  • Program Officer Name
    RAO, MALLA R.
  • Budget Start Date
    7/1/2008 - 16 years ago
  • Budget End Date
    6/30/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    2
  • Suffix
  • Award Notice Date
    8/8/2008 - 15 years ago

The role of CD28- cells in human Chagas' disease

[unreadable] DESCRIPTION (provided by applicant): The long-term aim of this research project is to gain a better understanding of the involvement of defined T- cell subpopulations in the establishment of protective and/or pathogenic immune responses in human Chagas' disease, a prevalent and endemic parasitic disease caused by the infection with Trypanosoma cruzi. Through a series of comprehensive mechanistic studies we will dissect the role of CD4+ and CD8+ T cells with differential expression of CD28 in the dynamics of the immune response in human Chagas' disease. Specific aims are: 1.Determine the adhesion molecule expression by CD28+ and CD28- T cells from individuals with different clinical forms of Chagas' disease; 2. Determine the intensity and specificity of the cytotoxic function of CD28+ and CD28- T cells from individuals with different clinical forms of Chagas' disease; 3. Determine the regulatory function of CD28+ and CD28- T cells from individuals with different clinical forms of Chagas' disease. To perform these studies we will use peripheral blood mononuclear cells from a selected group of chagasic patients, carefully classified as belonging to the indeterminate or severe cardiac clinical forms. Cellular recruitment potential, cytotoxicity and regulatory functions will be evaluated ex vivo and after in vitro stimulation with parasite, as well as autologous antigens, through the analysis of expression of surface or intracellular molecules by FACS and by biological assays. These studies will greatly improve the knowledge on Chagas' disease immunopathology by clarifying how CD28+ and CD28- sub- populations relate to the differential clinical evolution of disease. We hope that the new concepts derived from our findings will allow for the identification of markers of disease evolution and/or morbidity, offering new possibilities of clinical intervention to benefit the 17 million infected people. Transcending the limits of Chagas' disease, our findings will add to our knowledge on the biology of human T cells with differential expression of CD28, opening new possibilities of studies in other human diseases. Finally, depending largely on a Brazilian scientific core of researchers and students, the implementation of these studies will also lead to increased research capacities in Brazil through intense collaborations with international and national specialists. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R03
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    52974
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:52974\
  • Funding Mechanism
  • Study Section
    PTHE
  • Study Section Name
    Pathogenic Eukaryotes Study Section
  • Organization Name
    UNIVERSIDADE FEDERAL DE MINAS GERAIS
  • Organization Department
  • Organization DUNS
    899644116
  • Organization City
    BELO HORIZONTE
  • Organization State
  • Organization Country
    BRAZIL
  • Organization Zip Code
    31270-901
  • Organization District
    BRAZIL